SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
MRLN

Merlin, Inc. (NASDAQ:MRLN)

US · Delayed Price · Currency is USD
Industrials · Aerospace & Defense
$0.80-$0.08 (-9.36%)
 
Market cap
$77.2M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 17, 2026
Market Cap$77.22M-92.4%
Revenue (ttm)$6.66M+284.8%
Net Income-$73.81M-210.6%
EPS-$2.26-219.8%
Shares Out96.52M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,204,051
Open$0.86
Previous Close$0.88
Day's Range$0.79 - $0.88
52-Week Range$0.74 - $17.00
Beta1.78
AnalystsBuy
Price Target$9.00(+1025.00%)
Earnings DateFeb 11, 2027

About MRLN

Merlin, Inc. is a US-based developer of cost-effective, takeoff-to-touchdown autonomy for both legacy and next-generation airborne systems. Its aircraft-agnostic, AI-powered software is purpose-built for military and civil programs and is powering an expanding range of missions and aircraft, proven through numerous autonomous flights from test facilities worldwide. The company works with military customers to address national security challenges through safe and reliable autonomy.

Address
129 South Street, Boston, MA, 02111, US
Market Cap
77 million
Employees
3
Industrial Classification
Aerospace & Defense

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$3.51K
Bought
$1.47K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

When insiders bought and sold

1 year · open-market trades only
Closing Price Purchase Sale
$0.72$8.81$16.89AprJunAugOct

Analyst consensus

Moderate Buy
1 Buy0 Hold0 SellAvg target $9.00 (+1025.0%)

1 firm rating MRLN in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From MRLN’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-9.36%
5 Days
-28.57%
1 Month
-3.66%
6 Months
-88.72%
1 Year
-92.37%

$MRLN stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in MRLN holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by MRLN's directors and management

Net Shares Purchased by Insiders−200−10002025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

MRLN Estimated quarterly lobbying spending

Source: U.S. Senate LDA

MRLN Revenue by Segment or Geography

MRLN's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New MRLN patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to MRLN from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in MRLN

VXFVanguard Extended Market ETF$368.97K
SCHASchwab U.S. Small-Cap ETF$192.99K
SCHBSchwab U.S. Broad Market ETF$27.37K
ISCBiShares Morningstar Small-Cap ETF$2

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from MRLN’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
72

News check: Leadership transition, contract wins ($8.9M task order, AFRICOM challenge award), and Q3 earnings report indicate operational momentum and new business development despite executive change.

Recent Insider Activity

Buys
5
Sells
4
Buy Value
$1.47K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.